|Articles|January 1, 2015
- BioPharm International-01-01-2015
- Volume 28
- Issue 1
BioPharm International, January 2015 Issue (PDF)
Click the title above to open the BioPharm International January 2015 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 11 years ago
Great Expectations from New European Commissionalmost 11 years ago
Analyzing Protein Aggregation in Biopharmaceuticalsalmost 11 years ago
Raw Materials and the Development Cyclealmost 11 years ago
Fill/Finish Capacity Use for Biologicsalmost 11 years ago
Politics and Patients to Shape Pharma in 2015almost 11 years ago
Standards Organizations Updatealmost 11 years ago
Adopting the Product Lifecycle Approachalmost 11 years ago
Ligand-Binding Assays and the Determination of Biosimilarityalmost 11 years ago
Drug Breakthroughs, with Some Reservationsalmost 11 years ago
Technologies and Practices Must Evolve to Meet DemandNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
CPHI Frankfurt 2025 Highlights Global Pharma Innovation and Manufacturing Leadership
2
AstraZeneca Lupus Treatment Support in EU Opens Door for Self-Administration Options
3
A-TEEM: A Novel, Powerful Tool for Evaluating and Monitoring Cell Culture Media
4
Executive Summary: Mastering Nitrosamines Analysis With Streamlined LC-MS/MS Solutions
5
